WYAMINE SULFATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Wyamine Sulfate, and what generic alternatives are available?
Wyamine Sulfate is a drug marketed by Baxter Hlthcare Corp and is included in one NDA.
The generic ingredient in WYAMINE SULFATE is mephentermine sulfate. There is one drug master file entry for this compound. Additional details are available on the mephentermine sulfate profile page.
Summary for WYAMINE SULFATE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 30 |
Patent Applications: | 99 |
Formulation / Manufacturing: | see details |
DailyMed Link: | WYAMINE SULFATE at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for WYAMINE SULFATE
US Patents and Regulatory Information for WYAMINE SULFATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Baxter Hlthcare Corp | WYAMINE SULFATE | mephentermine sulfate | INJECTABLE;INJECTION | 008248-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Baxter Hlthcare Corp | WYAMINE SULFATE | mephentermine sulfate | INJECTABLE;INJECTION | 008248-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |